Gabapentin Withdrawal Syndrome
Author:
- 1 July 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 24 (4) , 245-246
Abstract
Gabapentin (GBP) has gained wide acceptance in the treatment of pain, migraine, bipolar illness, and epilepsy. It has a relatively benign side effect profile, lacks significant drug interactions, is not liver metabolized, and is renally excreted. Herein three cases are presented that demonstrate withdrawal symptoms after abrupt discontinuation of GBP. Clinicians are encouraged to taper GBP dosage, especially when patients have taken high doses, and to warn patients of possible adverse effects of abruptly discontinuing GBP themselves.Keywords
This publication has 5 references indexed in Scilit:
- A Case Report of Reduction in Alcohol Craving and Protection Against Alcohol Withdrawal by GabapentinThe Journal of Clinical Psychiatry, 1999
- Gabapentin: A Review of Published Experience in the Treatment of Bipolar Disorder and Other Psychiatric ConditionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Gabapentin Treatment of Alcohol WithdrawalAmerican Journal of Psychiatry, 1998
- GabapentinThe Lancet, 1994
- Gabapentin as an antiepileptic drug in man.Journal of Neurology, Neurosurgery & Psychiatry, 1987